Subscription Status of Modern Diagnostic & Research Centre IPO

Modern Diagnostic and Research Centre Limited’s IPO has closed on a very strong note, with final subscription standing at 350.49 times as of 6:57 PM on January 2, 2026, reflecting overwhelming investor appetite across all categories.

The Non-Institutional Investor (NII) segment remained the biggest driver till the close, ending at 519.38 times subscription. Within this, the HNI portion stayed exceptionally high at 856.35 times, while the smaller-ticket NII category closed at 386.91 times, indicating deep and broad-based participation.

Retail demand also remained robust into the final hour, with the individual investor category closing at 342.46 times, supported by nearly 1.46 lakh applications.

Institutional participation held firm, with the QIB segment closing at 193.51 times, backed by continued interest from foreign and domestic institutions.

Price-wise data shows bids were consistently clustered across the band, with volumes holding steady even at the upper end of ₹90, underlining strong conviction till the final moments.

With bidding now concluded, attention shifts to allotment and listing, following one of the most heavily subscribed SME IPOs in recent times.

Modern Diagnostic and Research Centre Limited’s IPO has witnessed an exceptional surge in the final hour of bidding, with overall subscription climbing to 348.07 times as of 4:25 PM on January 2, 2026, underscoring intense investor demand across categories.

The Non-Institutional Investor (NII) segment continues to dominate the book, now subscribed 518.86 times. Within this, the HNI category has scaled to an extraordinary 856.35 times, reflecting aggressive high-value bidding into the closing phase. The smaller-ticket NII bucket has also surged to 384.78 times, indicating broad-based participation.

Retail momentum has strengthened further, with the individual investor category subscribed 337.55 times, supported by a sharp rise in applications during the late session.

Institutional interest has also picked up meaningfully, with the QIB segment reaching 193.51 times, driven by fresh bids from foreign and domestic institutions in the final stretch.

Price-wise demand remains robust across the band, with bids firmly holding even at the upper end of ₹90, highlighting sustained confidence as the IPO heads toward closure.

With bidding set to conclude shortly, market participants are now closely watching whether final-minute flows push the subscription to even higher levels by the end of the session.

Modern Diagnostic and Research Centre Limited’s IPO continues to witness exceptionally strong last-hour participation, with overall subscription rising to 307.65 times as of 3:12 PM on January 2, 2026, underlining sustained and aggressive bidding on the final day.

The surge remains broad-based, led by non-institutional and retail investors, while institutional participation has also strengthened meaningfully in the late session.

The Non-Institutional Investor (NII) segment is now subscribed 479.58 times, driven by a sharp spike in the HNI category, which has climbed to 799.91 times, reflecting aggressive high-value bidding as the issue approaches close. The smaller-ticket NII bucket has also seen strong traction, reaching 338.48 times subscription.

Retail participation continues to scale rapidly, with the individual investor category now subscribed 283.01 times, supported by a steady rise in applications through the late afternoon.

Institutional demand has also picked up further, with the QIB segment rising to 176.53 times, indicating strong late-stage participation from this category.

Price-wise, bids have expanded sharply across the band, with demand holding firm even at the upper end of ₹90, signalling sustained investor confidence as the IPO heads into its final phase of bidding.

Modern Diagnostic and Research Centre Limited’s IPO has seen another powerful surge in bids during the late afternoon session, with overall subscription jumping to 264.19 times as of 2:50 PM on January 2, 2026, reflecting relentless investor appetite on the final day of bidding.

The rally continues to be led by non-institutional and retail investors, while institutional participation has also intensified materially.

The Non-Institutional Investor (NII) segment has now been subscribed 412.88 times, driven by an exceptional spike in the HNI category, which has surged to 690.68 times, highlighting aggressive high-value participation as the issue heads toward close. The smaller-ticket NII bucket has also scaled sharply, reaching 287.23 times subscription.

Retail participation has strengthened further, with the individual investor category now subscribed 244.32 times, supported by a sharp rise in applications through the afternoon session.

Institutional demand has continued to build, with the QIB segment climbing to 148.31 times, indicating strong late-stage participation from this category.

Price-wise, bid volumes have expanded sharply across the band, with demand remaining firm even at the upper end of ₹90, underscoring sustained confidence despite the rapid escalation in overall oversubscription.

With the final hours of bidding underway, market participants are now watching whether last-hour inflows push the IPO to even higher closing subscription levels.

Modern Diagnostic and Research Centre Limited’s IPO continues to attract heavy last-day inflows, with overall subscription climbing to 210.01 times as of 2:23 PM on January 2, 2026, reflecting sustained and accelerating demand across investor categories.

The momentum is being driven primarily by non-institutional and retail investors, while institutional participation has also strengthened meaningfully through the afternoon session.

The Non-Institutional Investor (NII) segment has now been subscribed 311.57 times, led by the HNI category, which has surged to 517.35 times, underscoring aggressive high-value bidding as the issue approaches closure. The smaller-ticket NII bucket has also scaled sharply, reaching 224.64 times subscription.

Retail participation continues to build, with the individual investor category now subscribed 205.11 times, supported by a steady rise in applications during the afternoon.

Institutional interest has strengthened further, with the QIB segment moving up to 115.74 times, indicating notable late participation from this category.

Price-wise demand remains strong across the band, with bids holding firm even at the upper end of ₹90, signalling sustained confidence despite the rapid escalation in oversubscription.

With several hours still remaining before bidding closes, the market is watching whether final-hour flows push the IPO well beyond current subscription levels by the end of the session.

Modern Diagnostic and Research Centre Limited’s IPO continues to see explosive last-day buying, with overall subscription jumping to 184.74 times as of 1:56 PM on January 2, 2026, underscoring exceptionally strong investor appetite across categories.

The surge remains led by non-institutional and retail investors, while institutional participation has also strengthened materially during the afternoon session.

The Non-Institutional Investor (NII) segment has now been subscribed 280.94 times, driven by the HNI category, which has surged to an extraordinary 469.34 times, reflecting aggressive high-value bidding as the issue approaches closure. The smaller-ticket NII bucket has also seen strong traction, reaching 196.73 times subscription.

Retail participation has continued to build rapidly, with the individual investor category now subscribed 182.04 times, supported by a sharp rise in applications through the early afternoon.

Institutional interest has strengthened further, with the QIB segment climbing sharply to 92.09 times, aided by fresh bids entering during the afternoon window.

Price-wise demand has expanded significantly across the band, with bids remaining firm even at the upper end of ₹90, indicating sustained confidence despite the rapid escalation in overall oversubscription.

With several hours still remaining before bidding closes, the market is now watching whether final-hour momentum pushes the IPO even further by end of day.

Modern Diagnostic and Research Centre Limited’s IPO has witnessed another sharp surge in bids during the early afternoon session, with overall subscription climbing to 146.72 times as of 1:10 PM on January 2, 2026, reflecting exceptionally strong investor appetite on the final day of bidding.

The rally continues to be driven by non-institutional and retail investors, alongside a significant acceleration in institutional participation.

The Non-Institutional Investor (NII) segment has now been subscribed 235.64 times, led by the HNI category, which has surged to an extraordinary 395.38 times, highlighting aggressive high-value participation as the issue heads toward closure. The smaller-ticket NII category has also strengthened further, reaching 161.49 times subscription.

Retail interest has built sharply, with the individual investor category now subscribed 149.49 times, supported by a steady rise in applications through the early afternoon session.

Institutional participation has picked up meaningfully, with the QIB segment jumping to 51.88 times, aided by fresh inflows during the post-lunch window.

Price-wise, bid volumes have expanded sharply across the band, with demand remaining firm even at the upper end of ₹90, indicating sustained confidence despite the rapid escalation in overall oversubscription.

With several hours still remaining before bidding closes, market participants are closely watching whether final-hour momentum pushes the IPO into even higher territory by the end of the session.

Modern Diagnostic and Research Centre Limited’s IPO has seen an extraordinary surge in bids during the early afternoon session on the final day, with overall subscription jumping to 122.45 times as of 12:40 PM on January 2, 2026.

The rally is being powered by heavy non-institutional and retail participation, alongside a notable pickup in institutional interest.

The Non-Institutional Investor (NII) segment has surged to 206.56 times, with the HNI category alone subscribed an exceptional 346.68 times, reflecting aggressive high-value bidding as the issue heads toward closure. Even the smaller-ticket NII bucket has crossed 141 times, underlining broad-based demand within the segment.

Retail momentum has strengthened further, with the individual investor category now subscribed 131.55 times, supported by a sharp rise in applications through the noon session.

Institutional participation has also picked up materially, with the QIB segment climbing to 21.46 times, aided by fresh bids entering during the post-noon window.

Price-wise demand has expanded sharply across the band, with bids remaining firm even at the upper end of ₹90, indicating sustained confidence despite the rapid escalation in oversubscription.

With several hours still remaining before bidding closes, market participants are closely watching whether final-hour flows push the IPO significantly higher by end of day.

Modern Diagnostic and Research Centre Limited’s IPO has seen another sharp surge in demand around noon on the final day of bidding, with overall subscription jumping to 94.09 times as of 12:07 PM on January 2, 2026.

The acceleration is now visible across all investor categories, with non-institutional and retail investors continuing to dominate the order book.

The Non-Institutional Investor (NII) segment has surged to 156.46 times, led by the HNI category, which is now subscribed a massive 262.02 times, reflecting aggressive high-value bidding as the issue heads toward closure. The smaller-ticket NII bucket has also crossed 108 times, indicating broad-based participation.

Retail momentum has strengthened further, with the individual investor category subscribed 105.77 times, supported by a steady rise in applications through the late morning and early afternoon session.

Institutional participation has also picked up, with the QIB segment moving up to 10.62 times, aided by fresh bids during the noon hour.

Price-wise data shows a sharp jump in absolute demand across the band, with bids remaining firm even at the upper end of ₹90, underlining sustained confidence despite the rapid escalation in oversubscription.

With several hours still left before bidding closes, the market is now watching whether final-hour flows push the IPO into triple-digit subscription territory by close of trade.

Modern Diagnostic and Research Centre Limited’s IPO continues to see intense last-day buying, with overall subscription rising to 78.02 times as of 11:31 AM on January 2, 2026, reflecting sustained and broad-based investor interest.

The surge remains firmly driven by non-institutional and retail investors.

The Non-Institutional Investor (NII) category is now subscribed 126.74 times, led by the HNI segment, which has surged to 211.45 times, underscoring aggressive high-value participation as the issue approaches closure. The smaller-ticket NII bucket has also strengthened further, with subscription climbing to 89.33 times.

Retail interest has continued to build, with the individual investor category now subscribed 89.37 times, supported by a steady rise in applications through the late morning session.

The QIB segment remains unchanged at 8.95 times, indicating limited incremental participation from institutional investors so far.

Price-wise bidding has expanded sharply across the band, with volumes remaining strong even at the upper end of ₹90, pointing to sustained confidence despite the rapid escalation in overall demand.

With several hours still remaining before bidding closes, market participants are closely tracking whether final-day momentum pushes the IPO well beyond current subscription levels by the end of the session.

Modern Diagnostic and Research Centre Limited’s IPO continues to witness strong last-day momentum, with overall subscription climbing to 70.18 times as of 11:10 AM on January 2, 2026, driven by sharp inflows from non-institutional and retail investors.

The Non-Institutional Investor (NII) segment remains the key driver, now subscribed 115.82 times. Within this, the HNI category has surged to 194.03 times, reflecting aggressive high-value bidding as the issue approaches close. The smaller-ticket NII bucket has also seen sustained traction, reaching 79.98 times subscription.

Retail participation continues to strengthen, with the individual investor category subscribed 78.81 times, supported by a steady rise in applications through the late morning session.

The QIB segment remains stable at 8.95 times, showing limited incremental movement compared with earlier updates.

Price-wise demand has expanded sharply across the band, with bids remaining firm even at the upper end of ₹90, indicating continued investor confidence despite the rapid escalation in overall subscription.

With several hours still remaining before bidding closes, market participants are closely tracking whether final-day flows push the IPO to substantially higher closing subscription levels.

Momentum in the Modern Diagnostic and Research Centre Limited IPO continues to intensify on the final day of bidding, with overall subscription climbing to 60.94 times as of 10:55 AM on January 2, 2026.

The surge is being led decisively by non-institutional and retail investors, where demand has scaled sharply within a short span of time.

The Non-Institutional Investor (NII) category is now subscribed 98.02 times, with the HNI segment alone oversubscribed 163.32 times, underlining aggressive last-day positioning. The smaller-ticket NII bucket has also seen sustained traction, crossing 69.52 times subscription.

Retail participation has strengthened further, with the individual investor category reaching 69.25 times, supported by a sharp rise in application count through the morning session.

The QIB segment remains steady at 8.95 times, showing limited incremental movement compared with earlier updates.

Price-wise data shows a sharp jump in absolute bid quantities across the band, with volumes at the upper end of ₹90 holding firm, indicating continued confidence despite the rapid escalation in oversubscription.

With several hours still remaining before bidding closes, the market is now watching whether final-day flows push the IPO into significantly higher subscription territory by the end of the session.

Modern Diagnostic and Research Centre Limited’s IPO has witnessed a dramatic spike in demand on the final day of bidding, with overall subscription soaring to 50.39 times as of 10:28 AM on January 2, 2026.

The sharp acceleration is being driven overwhelmingly by non-institutional and retail investors.

The Non-Institutional Investor (NII) segment has emerged as the clear standout, now subscribed 82.63 times, with the HNI portion alone oversubscribed 138.76 times, reflecting aggressive last-day participation. Even the smaller-ticket NII category has crossed 56 times, underscoring broad-based interest within the segment.

Retail participation has also strengthened materially, with the individual investor category now subscribed 55.44 times, supported by a sharp rise in application count during the morning session.

The QIB segment has seen marginal incremental participation, inching up to 8.95 times, remaining relatively stable compared with earlier data points.

Price-wise bidding shows a significant jump in absolute demand, with bids across the price band rising sharply and volumes at the upper end of ₹90 staying firmly intact, indicating sustained confidence despite the rapid increase in overall subscription.

With several hours still left before bidding closes, market participants are now watching whether final-day momentum pushes the IPO into even higher subscription territory by close of trade.

Modern Diagnostic and Research Centre Limited’s IPO has picked up incremental demand on the final day of bidding, with overall subscription rising to 30.34 times as of 10:01 AM on January 2, 2026.

Investor participation continues to be led by non-institutional investors, where the category is now subscribed 42.52 times. Within this, HNI demand remains strong at 68.74 times, reflecting aggressive bidding early on the last day. Retail interest has also strengthened, with the individual investor portion reaching 35.53 times subscription.

The QIB segment remains steady at 8.94 times, with no material change from Day 2 levels.

Price-wise demand data indicates continued concentration across the band, with bids at the upper end of ₹90 holding firm alongside rising volumes at lower prices, pointing to sustained confidence as bidding progresses.

With several hours of subscription still remaining, the market will closely track whether late institutional and retail flows push the IPO to even higher closing-day subscription levels.

Modern Diagnostic and Research Centre Limited’s IPO remains in strong demand as it heads into the final day of subscription today. By the end of Day 2, the issue was subscribed 28.77 times, led by sustained interest from HNIs and retail investors.

The non-institutional investor (NII) segment continues to be the standout, clocking a 39.61x subscription, with HNIs alone bidding nearly 64 times their reserved quota. Retail participation also remains robust, with the individual investor category subscribed 33.85 times so far.

Demand from qualified institutional buyers (QIBs) stood at 8.94 times, indicating selective but steady institutional participation.

Price-wise data shows bids clustered across the band, with volumes remaining strong even at the upper end of ₹90, suggesting investor comfort with the valuation.

With one day of bidding still left, the market will closely watch whether last-day momentum further lifts overall subscription, especially from institutions and late retail bidders.

Final allotment is expected on January 5, with listing tentatively scheduled for January 7.